Lyra Therapeutics, Inc. (LYRA) Financial Statements (2024 and earlier)

Company Profile

Business Address 480 ARSENAL WAY
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments116,15082,70797,894109,558120,66933,755
Cash and cash equivalents54,36122,01932,550109,558120,66933,755
Short-term investments61,78960,68865,344   
Restricted cash and investments 303  329329 
Other undisclosed current assets1,8002,0922,9352,3431,3836,800
Total current assets:118,25384,799100,829112,230122,38140,555
Noncurrent Assets
Operating lease, right-of-use asset1,4201,8252,2236088601,109
Property, plant and equipment5602,0042,2433,7534,0094,275
Restricted cash and investments1,0891,3921,3921,0891,089329
Other noncurrent assets4,3533,8483,2811,7831,6961,077
Total noncurrent assets:7,4229,0699,1397,2337,6546,790
TOTAL ASSETS:125,67593,868109,968119,463130,03547,345
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,1883,9515,5919,9496,3936,037
Employee-related liabilities3,0822,0871,533
Accounts payable4,1883,9512,6162,9001,6702,408
Accrued liabilities   2,9753,9672,6362,096
Deferred revenue1,4971,5101,2752,7302,54614,223
Other liabilities   65929911540
Other undisclosed current liabilities8,4268,6936,9456271,5531,665
Total current liabilities:14,11114,15414,47013,60510,60721,965
Noncurrent Liabilities
Long-term debt and lease obligation:    3399
Liabilities, other than long-term debt12,98713,62314,74412,63313,1762,024
Deferred revenue12,98713,43214,07712,63313,1762,024
Operating lease, liability 1916673399
Total noncurrent liabilities:12,98713,62314,74412,63613,1792,123
Total liabilities:27,09827,77729,21426,24123,78624,088
Equity
Equity, attributable to parent98,57766,09180,75493,222106,24923,257
Common stock503232323213
Additional paid in capital379,102331,001329,387327,630325,891228,552
Accumulated other comprehensive income (loss)(27)(12)10   
Accumulated deficit(280,548)(264,930)(248,675)(234,440)(219,674)(205,308)
Total equity:98,57766,09180,75493,222106,24923,257
TOTAL LIABILITIES AND EQUITY:125,67593,868109,968119,463130,03547,345

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues45841011359525468
Gross profit:45841011359525468
Operating expenses(16,961)(17,723)(15,166)(15,185)(14,925)(12,393)
Operating loss:(16,503)(17,313)(15,155)(14,826)(14,400)(11,925)
Nonoperating income
(Investment Income, Nonoperating)
8971,072933603414
Loss from continuing operations before income taxes:(15,606)(16,241)(14,222)(14,766)(14,366)(11,911)
Income tax expense(12)(14)    
Other undisclosed loss from continuing operations   (13)   
Loss from continuing operations:(15,618)(16,255)(14,235)(14,766)(14,366)(11,911)
Loss before gain (loss) on sale of properties:(14,766)(14,366)(11,911)
Net loss available to common stockholders, diluted:(15,618)(16,255)(14,235)(14,766)(14,366)(11,911)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(15,618)(16,255)(14,235)(14,766)(14,366)(11,911)
Comprehensive loss:(15,618)(16,255)(14,235)(14,766)(14,366)(11,911)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(15)(22)10   
Comprehensive loss, net of tax, attributable to parent:(15,633)(16,277)(14,225)(14,766)(14,366)(11,911)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: